← Eichor
Condition: Dapagliflozin Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Dapagliflozin

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Hea
Phase 4 · 12 location(s) · Herlev and Gentofte Hospital · NCT06642272A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Alb
Phase 2 · 71 location(s) · AstraZeneca · NCT07222917Assessing the Clinical Outcomes of Dapagliflozin Versus Acetazolamide in Patients With Acute Heart Failure
Phase 2/Phase 3 · 1 location(s) · Mansoura University · NCT06783166The Efficacy and Safety of Dapagliflozin in the Treatment of Hereditary Kidney Disease With Proteinuria in Children
Phase 3 · 1 location(s) · Children's Hospital of Fudan University · NCT06890143Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Phase 2/Phase 3 · 1 location(s) · Mostafa Bahaa · NCT05986136Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary
Phase 4 · 1 location(s) · The University of Hong Kong · NCT06668389Dapagliflozin for Cardio-renal Protection After ICU Discharge
Phase 3 · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07025629SGLT2i, Pioglitazone, and Ketone Production in T1D
Phase 3 · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT07056699Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
Phase 1/Phase 2 · 1 location(s) · Northwestern University · NCT05719714A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults
Phase 3 · 272 location(s) · AstraZeneca · NCT07662109Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation
Phase 4 · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT06560801Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema
Phase 2 · 1 location(s) · Alexandria University · NCT06845163Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Phase 2 · 1 location(s) · Minneapolis Heart Institute Foundation · NCT05305911The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure
Phase 4 · 2 location(s) · The University of Hong Kong · NCT07482943DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05764057The DAPA-MEMRI Trial
NA · 1 location(s) · University of Edinburgh · NCT04591639Acute Reno-Cardiac Action of Dapagliflozin In Advanced Heart Failure Patients on Heart Transplant Waiting List
NA · 11 location(s) · Central Hospital, Nancy, France · NCT06868797Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease
Phase 1 · 1 location(s) · University of Virginia · NCT05762952Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma
EARLY_Phase 1 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07235280Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)
Phase 2 · 1 location(s) · University of Edinburgh · NCT06887062Effect of DAPAglifozin on MYOcardial Remodeling of Breast CANCER Patients Treated with Anthracycline Based Chemotherapy
Phase 3 · 1 location(s) · University of Campinas, Brazil · NCT06711185RECURrence of Atrial Fibrillation After Cardioversion of Patients Randomized to Dapagliflozin or Usual Care
Phase 3 · 7 location(s) · Region Stockholm · NCT07187570A Study of Apabetalone in Subjects With Long -COVID
Phase 2/Phase 3 · 3 location(s) · Resverlogix Corp · NCT06590324A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Perio
Phase 4 · 1 location(s) · University of Michigan · NCT06785116Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with CKD
Phase 2 · 1 location(s) · Tor Biering-Sørensen · NCT05359263Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity
Phase 2 · 1 location(s) · Tanta University · NCT06427226A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled Wi
Phase 3 · 1 location(s) · Hanmi Pharmaceutical Company Limited · NCT07379333STunning in Acute Myocardial Infarction - BAS
Phase 4 · 1 location(s) · Vastra Gotaland Region · NCT06562582A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Part
Phase 2 · 15 location(s) · AstraZeneca · NCT06942910Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Phase 3 · 942 location(s) · AstraZeneca · NCT06677060
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.